Abstract
The control period of stable patients is allowed to be extended to avoid exposure to anticoagulant patients
Keywords
Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Oral anticoagulant treatment; Dicumarinics; International Normalized Ratio
Bibliographic citation
Ampliació del període de control de tractament anticoagulant oral (TAO) [cartell]. Barcelona: Institut Català de la Salut; 2020.
Audience
Professionals
Use this identifier for quote and/or link this document
https://hdl.handle.net/11351/4818This item appears in following collections
The following license files are associated with this item: